Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
P/S ratio for Spero Therapeutics (SPRO)
P/S ratio as of May 2024 (TTM): 0.8607
According to Spero Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.860749. At the end of 2023 the company had a P/S ratio of 0.8054.
P/S ratio history for Spero Therapeutics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.8054 | -56.32% |
| 2022 | 1.84 | |
| 2021 | N/A | -100% |
| 2020 | > 1000 | 13369.5% |
| 2019 | 16.3 | -92.86% |
| 2018 | 229 | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 IBM IBM | 2.44 | 183.68% | 🇺🇸 USA |
 Thomson Reuters
TRI | 10.1 | 1,076.03% | 🇨🇦 Canada |
 Franklin Covey FC | 1.85 | 115.17% | 🇺🇸 USA |